Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the eve of personalized medicine in oncology.

Literature DB >> 18794109

On the eve of personalized medicine in oncology.

Timothy J Yeatman¹, James Mule, William S Dalton, Dan Sullivan.

Abstract

Entities: Disease Gene Species

Mesh：

Year: 2008 PMID： 18794109 PMCID： PMC2650840 DOI： 10.1158/0008-5472.CAN-08-1374

Source DB: PubMed Journal: Cancer Res ISSN： 0008-5472 Impact factor: 12.701

× No keyword cloud information.

2 in total

1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors: Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal: N Engl J Med Date: 2004-12-10 Impact factor: 91.245

2. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

Authors: Zhong Zheng; Tingan Chen; Xueli Li; Eric Haura; Anupama Sharma; Gerold Bepler
Journal: N Engl J Med Date: 2007-02-22 Impact factor: 91.245

2 in total

13 in total

1. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.

Authors: Dung-Tsa Chen; Ying-Lin Hsu; William J Fulp; Domenico Coppola; Eric B Haura; Timothy J Yeatman; W Douglas Cress
Journal: J Natl Cancer Inst Date: 2011-12-08 Impact factor: 13.506

Review 2. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Authors: Tarik Z Belhocine; Francis G Blankenberg; Marina S Kartachova; Larry W Stitt; Jean-Luc Vanderheyden; Frank J P Hoebers; Christophe Van de Wiele
Journal: Eur J Nucl Med Mol Imaging Date: 2015-08-16 Impact factor: 9.236

Review 3. Drug development and clinical trials--the path to an approved cancer drug.

Authors: Eric H Rubin; D Gary Gilliland
Journal: Nat Rev Clin Oncol Date: 2012-02-28 Impact factor: 66.675

4. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.

Authors: Domenico Coppola; Michael Nebozhyn; Farah Khalil; Hongyue Dai; Timothy Yeatman; Andrey Loboda; James J Mulé
Journal: Am J Pathol Date: 2011-05-03 Impact factor: 4.307

5. Formative research on perceptions of biobanking: what community members think.

Authors: John S Luque; Gwendolyn P Quinn; Francisco A Montel-Ishino; Mariana Arevalo; Shalanda A Bynum; Shalewa Noel-Thomas; Kristen J Wells; Clement K Gwede; Cathy D Meade
Journal: J Cancer Educ Date: 2012-03 Impact factor: 2.037

Review 6. Helicobacter pylori-induced alteration of epithelial cell signaling and polarity: a possible mechanism of gastric carcinoma etiology and disparity.

Authors: Mahasin A Osman; George S Bloom; Emmanuel A Tagoe
Journal: Cytoskeleton (Hoboken) Date: 2013-07-03

On the eve of personalized medicine in oncology.

1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

2. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.

Review 2. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.

Review 3. Drug development and clinical trials--the path to an approved cancer drug.

4. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.

5. Formative research on perceptions of biobanking: what community members think.

Review 6. Helicobacter pylori-induced alteration of epithelial cell signaling and polarity: a possible mechanism of gastric carcinoma etiology and disparity.

Review 7. Implementing personalized medicine in a cancer center.

8. Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.

9. Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation.

10. Models for prevention and treatment of cancer: problems vs promises.